Telomir

TELO

TELO Telomir NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    TELO Chart
    See on advanced chart >

    About

    Telomir Pharmaceuticals, Inc. were organized as a Florida corporation in August 2021. The company is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function...
    • Highlight
      A preclinical stage biotechnology company
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      02/09/2024
    • Established Date
      Invalid Date
    • Full-time Employees
      1
    • Address
      855 N Wolfe Street Suite 601 Baltimore Maryland 21205
    • Tel
      1-737-2890835
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock